Bharat Biotech has bagged the prestigious National Technology Award for 2018 from the Technology Development Board, Govt of India.
This prestigious award on innovative technologies, successfully developed and commercialized from India was bestowed on ROTAVAC®, by the Hon’ble President of India Shri. Ram Nath Kovind.
Launched by the government, ROTAVAC ® was introduced into the Universal Immunization Program in India during 2016, with initial implementation in 9 states with more states in the pipeline.
Till date, Bharat Biotech has supplied ~ 35 million doses to the UIP. ROTAVAC ® is already saving infant lives and lowering the cost of hospitalizations across India. The company has also initiated supply of WHO Prequalified ROTAVAC® to UNICEF and other Immunization programs worldwide.